LOGIN
TEAM
CONTACT US
COLLECTIONS
Bladder
Breast
Leukemia
Pancreas
Pediatric Liver
Sarcoma
HOME
You need to enable JavaScript to run this app page.
Leukemia
TCH-AML001
Model Details
Patient
PDX Model
Metastasis
Patient Treatment
Patient Information for Model: TCH-AML001
Patient Information
Clinical Timeline
Clinical Information at Collection
Clinical Biomarkers/Mutations
Model Information for Model: TCH-AML001
Model Details
Mutations (Cancer Gene Census List)
There are no omics data for this model.
CNV
Metastasis Information for Model: TCH-AML001
Patient
PDX
Central Nervous System
Gingiva
Liver
None
Orbital chloroma
Skin
Spleen
Testis
lymph nodes
retinas
tongue
Patient Treatment Information for Model: TCH-AML001
Event Id
Treatment
Treatment Setting
Age at Start
Age at End
Duration
Clinical Response
CNS Response
11
AAML1031 ADE10, ADE8, AE
De Novo
1.34
1.42
29 days
Complete Remission
CSF Negative
20
HDAC/Erwinia
Relapse
1.59
0.0
Unknown
Refractory
26
Ida/2CDA/dexamethasone
Relapse
1.67
0.0
Unknown
Morphologic Complete Response
CSF Negative
40
Multiple intensive regimens
Relapse
1.84
0.0
Unknown
Refractory
CSF Positive
45
MTX/VCR/PEG-asp
Palliative
1.99
0.0
Unknown
Refractory
CSF Positive
Timeout
Your session is about to expire. Click 'Stay Connected' to continue the session.
Stay Connected